Photo taken from Afreen Shariff/X
Oct 7, 2024, 19:13
Transforming Cancer Care MD-MD Consults and AI Solutions with Afreen Shariff – Citrus Oncology
Citrus Oncology posted on LinkedIn:
“Meet our Co-Founder, Dr. Afreen Shariff to learn how we can together change the outcomes of high grade and organ specific toxicities through our industry first MD-MD consults for side effects supported by companion AI solutions that drive insight and efficiency for your patients and oncologists.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 26, 2024, 09:55
Dec 26, 2024, 09:17
Dec 26, 2024, 09:11
Dec 26, 2024, 06:29
Dec 26, 2024, 05:37
Dec 26, 2024, 05:33
Dec 26, 2024, 05:30
If your team is attending Association of Cancer Care Centers, 2024 National Oncology Conference reach out to Afreen Shariff to set up a meeting now!”
Douglas Flora shared this post adding:
“Looking forward to seeing you there, Dr. Shariff! Who else should I look for at Association of Cancer Care Centers meeting next week?”
Source: Citrus Oncology/LinkedIn and Douglas Flora/LinkedIn
Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.
As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.